Measurement of patient outcome in arthritis
James F. Fries, Patricia W. Spitz, R. Guy Kraines, Halsted R. Holman
Arthritis & Rheumatism · 1980 · 4,414 citations
No retraction on record in OpenAlex.Check Crossref now
Cite this paper
Fries, J. F., Spitz, P. W., Kraines, R. G., & Holman, H. R. (1980). Measurement of patient outcome in arthritis. Arthritis & Rheumatism, 23(2), 137–145. https://doi.org/10.1002/art.1780230202
In text: (Fries et al., 1980)
Ask a question about this research
One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.
Abstract
A structure for representation of patient outcome is presented, together with a method for outcome measurement and validation of the technique in rheumatoid arthritis. The paradigm represents outcome by five separate dimensions: death, discomfort, disability, drug (therapeutic) toxicity, and dollar cost. Each dimension represents an outcome directly related to patient welfare. Quantitation of these outcome dimensions may be performed at interview or by patient questionnaire. With standardized, validated questions, similar scores are achieved by both methods. The questionnaire technique is preferred since it is inexpensive and does not require interobserver validation. These techniques appear extremely useful for evaluation of long term outcome of patients with rheumatic diseases.
Related papers
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation2018
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement2009
- The MOS 36-ltem Short-Form Health Survey (SF-36)1992
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions2016
- The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration2009
Metadata from OpenAlex (CC0). Citations are generated from the published record.